Skip to content
10-Q

Quarterly Report

BIOGEN INC. BIIB

0000875045-25-000049

← back to feed
Filed
Oct 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 29, 2025 146.7M sh
Shares Diluted Q3 2025 · Sep 30, 2025 147.1M sh
Shares Diluted Q3 2025 · Sep 30, 2025 146.8M sh
Shares Diluted Q3 2025 · Sep 30, 2024 146.1M sh
Shares Diluted Q3 2025 · Sep 30, 2024 146M sh
Capex Q3 2025 · Sep 30, 2025 $109.9M
Capex Q3 2025 · Sep 30, 2024 $114.4M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $1.69B
Operating Cash Flow Q3 2025 · Sep 30, 2024 $2.11B
Long Term Debt Q3 2025 · Sep 30, 2025 $6.29B
Long Term Debt Q3 2025 · Dec 31, 2024 $4.55B
Current Liabilities Q3 2025 · Sep 30, 2025 $3.29B
Current Liabilities Q3 2025 · Dec 31, 2024 $5.53B
Total Liabilities Q3 2025 · Sep 30, 2025 $11B
Total Liabilities Q3 2025 · Dec 31, 2024 $11.33B
Current Assets Q3 2025 · Sep 30, 2025 $8.94B
Current Assets Q3 2025 · Dec 31, 2024 $7.46B
Total Assets Q3 2025 · Sep 30, 2025 $29.21B
Total Assets Q3 2025 · Dec 31, 2024 $28.05B
Eps Diluted Q3 2025 · Sep 30, 2025 $3.17
Eps Diluted Q3 2025 · Sep 30, 2025 $9.14
Eps Diluted Q3 2025 · Sep 30, 2024 $2.66
Eps Diluted Q3 2025 · Sep 30, 2024 $9.35
Eps Basic Q3 2025 · Sep 30, 2025 $3.18
Eps Basic Q3 2025 · Sep 30, 2025 $9.16
Eps Basic Q3 2025 · Sep 30, 2024 $2.67
Eps Basic Q3 2025 · Sep 30, 2024 $9.38
Sga Expense Q3 2025 · Sep 30, 2025 $594.8M
Sga Expense Q3 2025 · Sep 30, 2025 $1.75B
Sga Expense Q3 2025 · Sep 30, 2024 $588.4M
Sga Expense Q3 2025 · Sep 30, 2024 $1.72B
Net Income Q3 2025 · Sep 30, 2025 $466.5M
Net Income Q3 2025 · Sep 30, 2025 $1.34B
Net Income Q3 2025 · Sep 30, 2024 $388.5M
Net Income Q3 2025 · Sep 30, 2024 $1.37B
Revenue Q3 2025 · Sep 30, 2025 $2.53B
Revenue Q3 2025 · Sep 30, 2025 $7.61B
Revenue Q3 2025 · Sep 30, 2024 $2.47B
Revenue Q3 2025 · Sep 30, 2024 $7.22B